Literature DB >> 34035752

Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.

Sara Lewin1, Fernando S Velayos2.   

Abstract

Hospitalization for inflammatory bowel disease is common and requires coordination of care. The goals of hospitalization are to markedly improve symptoms, transition management to an outpatient regimen, and prevent complications. Initially, providers should determine the phenotype and severity of disease flare and provide optimal medical salvage therapy for induction of disease remission. In addition, complications of Crohn's disease and ulcerative colitis should be addressed with testing for Clostridioides difficile and cytomegalovirus infections and pharmacologic venous thromboembolism prophylaxis, and early enteral feeding should be encouraged to optimize nutritional status. A standardized daily assessment to determine response to treatment should be performed. Objective measures of response to disease treatment that are measured within 3 to 4 days of hospitalization can predict which patients will benefit from either second-line rescue therapy or surgical intervention. These same measures can be used to determine readiness for hospital discharge. Safe discharge can be optimized with thorough patient education and a comprehensive outpatient follow-up plan.
Copyright © 2020, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Crohn’s disease; Ulcerative colitis; checklist; hospitalization; inflammatory bowel disease

Year:  2020        PMID: 34035752      PMCID: PMC8132655     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  58 in total

1.  Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Michael D Kappelman; Christopher F Martin; Joshua R Korzenik; Seth D Crockett
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

Review 2.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

3.  Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.

Authors:  Julajak Limsrivilai; Ryan W Stidham; Shail M Govani; Akbar K Waljee; Wen Huang; Peter D R Higgins
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-17       Impact factor: 11.382

Review 4.  Inpatient Management of Inflammatory Bowel Disease-Related Complications.

Authors:  Manreet Kaur; Robin L Dalal; Seth Shaffer; David A Schwartz; David T Rubin
Journal:  Clin Gastroenterol Hepatol       Date:  2020-01-09       Impact factor: 11.382

5.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

6.  Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

Authors:  Gunnar Järnerot; Erik Hertervig; Ingalill Friis-Liby; Lars Blomquist; Per Karlén; Christer Grännö; Mogens Vilien; Magnus Ström; Ake Danielsson; Hans Verbaan; Per M Hellström; Anders Magnuson; Bengt Curman
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

7.  Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.

Authors:  Zane R Gallinger; Amir Rumman; Kevin Pivovarov; Kyle J Fortinsky; A Hillary Steinhart; Adam V Weizman
Journal:  Inflamm Bowel Dis       Date:  2017-10       Impact factor: 5.325

Review 8.  Surgical Considerations in the Treatment of Small Bowel Crohn's Disease.

Authors:  Lillias Holmes Maguire; Karim Alavi; Ranjan Sudan; Paul E Wise; Andreas M Kaiser; Liliana Bordeianou
Journal:  J Gastrointest Surg       Date:  2016-12-13       Impact factor: 3.452

Review 9.  Predicting outcomes in acute severe ulcerative colitis.

Authors:  Nicholas T Ventham; Rahul Kalla; Nicholas A Kennedy; Jack Satsangi; Ian D Arnott
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-12-15       Impact factor: 3.869

10.  European evidence based consensus on surgery for ulcerative colitis.

Authors:  Tom Øresland; Willem A Bemelman; Gianluca M Sampietro; Antonino Spinelli; Alastair Windsor; Marc Ferrante; Philippe Marteau; Oded Zmora; Paulo Gustavo Kotze; Eloy Espin-Basany; Emmanuel Tiret; Giuseppe Sica; Yves Panis; Arne E Faerden; Livia Biancone; Imerio Angriman; Zuzana Serclova; Anthony de Buck van Overstraeten; Paolo Gionchetti; Laurents Stassen; Janindra Warusavitarne; Michel Adamina; Axel Dignass; Rami Eliakim; Fernando Magro; André D'Hoore
Journal:  J Crohns Colitis       Date:  2015-01       Impact factor: 10.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.